Peptide Legal Status in Washington
Enhanced state-level restrictions on compounding and distribution. Washington's Pharmacy Quality Assurance Commission enforces strict compounding standards. The state has additional requirements for telemedicine prescribing and limits on non-FDA-approved peptide distribution.
Key Facts
Washington Regulatory Details
Peptide Availability in Washington
| Peptide | FDA Status | Evidence | Availability |
|---|---|---|---|
| BPC-157 | Not Approved | C | Restricted |
| TB-500 (Thymosin Beta-4) | Not Approved | C | Restricted |
| GHK-Cu | Not Approved | B | Restricted |
| Ipamorelin | Not Approved | B | Restricted |
| CJC-1295 | Not Approved | B | Restricted |
| Sermorelin | Approved | A | Available by Rx |
| Tesamorelin | Approved | A | Available by Rx |
| Bremelanotide (PT-141) | Approved | A | Available by Rx |
| Semaglutide | Approved | A | Available by Rx |
| Tirzepatide | Approved | A | Available by Rx |
| AOD-9604 | Not Approved | C | Restricted |
| DSIP (Delta Sleep-Inducing Peptide) | Not Approved | D | Restricted |
| Epithalon (Epitalon) | Not Approved | C | Restricted |
| Selank | Not Approved | B | Restricted |
| Semax | Not Approved | B | Restricted |
| GHRP-2 | Not Approved | B | Restricted |
| GHRP-6 | Not Approved | B | Restricted |
| Hexarelin | Not Approved | B | Restricted |
| Melanotan II | Not Approved | C | Restricted |
| LL-37 | Not Approved | C | Restricted |
| Thymalin | Not Approved | C | Restricted |
| KPV | Not Approved | D | Restricted |
| Liraglutide | Approved | A | Available by Rx |
| Retatrutide | Not Approved | B | Restricted |
| Survodutide | Not Approved | B | Restricted |
Peptides in Washington: FAQ
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.